Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria, and AMH
Open accessThe DOI matches its OpenAlex record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
The polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility and a notable proportion of women of reproductive age are affected. It may constitute a risk factor for cancer development. Different factors could result in different manifestations and many of these are related to predispositions. It is essential to establish criteria to achieve an exact diagnosis of PCOS, especially among adolescent patients because of the overlap between features of PCO syndrome and physiological findings in puberty. Day by day the technology of ultrasonography is improving and accuracy is increasing, but remains dependent on the specific equipment available. Some factors are inter-related in determining PCOS prognosis. Serum AMH is synthesized by small antral follicles, which are precisely those seen on ultrasound and could help us to diagnose PCOS but there are many aspects that still require elucidation. In this mini- review we have attempted to identify some of these correlations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143 · cited 2×
“Finally the Androgen Excess Society defined PCOS as hyperandrogenism with ovarian dysfunction or polycystic ovaries (Azziz et al., 2006).”
BackgroundFauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976 · cited 1×
“…while Sultan and Paris proposes requiring four of five of: clinical hyperandrogenism, Oligomenorrhea or amenorrhea at least two years post menarche, biologic hyperandrogenism, insulin resistance, and polycystic ovary morphology (Carmina et al., 2010; Sultan and Paris, 2006; Fauser et al., 2012).”
BackgroundMarch, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Pigny, P., Merlen, E., Robert, Y., Cortet-Rudelli, C., Decanter, C., Jonard, S., & Dewailly, D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030727 · Cited by 709
Follicle dynamics and anovulation in polycystic ovary syndrome
Franks, S., Stark, J., & Hardy, K. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn015 · Cited by 581
The diagnosis of polycystic ovary syndrome in adolescents
Carmina, E., Oberfield, S. E., & Lobo, R. A. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.03.008 · Cited by 339
Abbott, D. H., Tarantal, A. F., & Dumesic, D. A. (2009) · American Journal of Primatology · doi:10.1002/ajp.20679 · Cited by 177
Zhang, H. Y., Guo, C. X., Zhu, F. F., Qu, P. P., Lin, W. J., & Xiong, J. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2568-z · Cited by 94 · cited 1×
“The heterogeneity seems to be adjusted by several factors, such as genetic factors, nutritional condition in the uterus, prenatal androgen exposure, insulin resistance, exaggerated adrenarche, and body weight changes (Abbott et al., 2009; Oberfield et al., 2011; Zhang et al., 2013).”
BackgroundRosenfield, R. L., Wroblewski, K., Padmanabhan, V., Littlejohn, E., Mortensen, M., & Ehrmann, D. A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.03.059 · Cited by 80
Diagnosis of Polycystic Ovary Syndrome: AMH in combination with clinical symptoms
Sahmay, S., Aydin, Y., Oncul, M., & Senturk, L. M. (2014) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-013-0149-0 · Cited by 71 · cited 2×
“There is a problem to solve; the absence of a worldwide standard for serum AMH assay and inability to define thresholds make application of serum AMH level more difficult (Spritzer, 2014; Sahmay et al., 2014).”
Background
Cited by
Targeting autophagy in obesity: from pathophysiology to management
Zhang, Y., Sowers, J. R., & Ren, J. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0009-1 · Cited by 338
Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome
Wang, J., Wu, D., Guo, H., & Li, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116940 · Cited by 322
Characterization of polycystic ovary syndrome among Flo app users around the world
Jain, T., Negris, O., Brown, D., Galic, I., Salimgaraev, R., & Zhaunova, L. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00719-y · Cited by 37
Unraveling PCOS: Exploring its causes and diagnostic challenges
Dar, M. A., Maqbool, M., Qadrie, Z., Ara, I., & Qadir, A. (2024) · Open Health · doi:10.1515/ohe-2023-0026 · Cited by 7
Metadata
- Authors
- Banimohammad, M., & Seghinsara, A. M.
- Venue
- PubMed
- Publisher
- National Institutes of Health
- Published
- 2017-01-01
- Volume
- 18
- Issue
- 1
- Pages
- 17-21
- OpenAlex
- W2593115523
- Cited by
- 192
- References
- 12
- FWCI
- 15.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.